Sachiko Okamoto

2.7k total citations
37 papers, 1.2k citations indexed

About

Sachiko Okamoto is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Sachiko Okamoto has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 18 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Sachiko Okamoto's work include CAR-T cell therapy research (27 papers), Virus-based gene therapy research (9 papers) and Renal and related cancers (9 papers). Sachiko Okamoto is often cited by papers focused on CAR-T cell therapy research (27 papers), Virus-based gene therapy research (9 papers) and Renal and related cancers (9 papers). Sachiko Okamoto collaborates with scholars based in Japan, Canada and United States. Sachiko Okamoto's co-authors include Junichi Mineno, Hiroshi Shiku, Hiroshi Handa, Yuki Yamaguchi, Tomoko Yamada, Naoto Inukai, Masaki Yasukawa, Hiroshi Fujiwara, Yasunori Amaishi and Hiroaki Ikeda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sachiko Okamoto

37 papers receiving 1.2k citations

Peers

Countries citing papers authored by Sachiko Okamoto

Since Specialization

Citations

This map shows the geographic impact of Sachiko Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachiko Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachiko Okamoto more than expected).

Fields of papers citing papers by Sachiko Okamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sachiko Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachiko Okamoto. The network helps show where Sachiko Okamoto may publish in the future.

Co-authorship network of co-authors of Sachiko Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Sachiko Okamoto. A scholar is included among the top collaborators of Sachiko Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sachiko Okamoto. Sachiko Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model 2023 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), Katsunori Sasaki, Osamu Sato, Takahiro Tsuchikawa, Linan Wang, Yasunori Amaishi, Sachiko Okamoto, Junichi Mineno, Yoshifumi Hirokawa, Kanako C. Hatanaka, Yutaka Hatanaka, (unknown), Hiroshi Shiku, Satoshi Hirano	5
2	Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells 2023 ·Cancers ·Osamu Sato, Takahiro Tsuchikawa, Takuma Kato, Yasunori Amaishi, Sachiko Okamoto, Junichi Mineno, (unknown), Katsunori Sasaki, Toru Nakamura, (unknown), Tomohiro Suzuki, Linan Wang, (unknown), Kanako C. Hatanaka, Tomoko Mitsuhashi, Yutaka Hatanaka, Hiroshi Shiku, Satoshi Hirano	11
3	T cell receptor gene‐modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft‐versus‐host disease 2023 ·Cancer Science ·(unknown), (unknown), Kiyoshi Yasui, Isao Tawara, (unknown), Sachiko Okamoto, Junichi Mineno, Naohiro Seo, Hiroshi Shiku, Susumu Eguchi, Hiroaki Ikeda	6
4	Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction 2023 ·Scientific Reports ·Hiroki Hayashi, Jiao Sun, (unknown), (unknown), (unknown), Tomoyuki Nishikawa, (unknown), (unknown), Shota Yoshida, Satoshi Baba, (unknown), Munehisa Shimamura, Sachiko Okamoto, Yasunori Amaishi, Hideto Chono, Junichi Mineno, Hiromi Rakugi, Ryuichi Morishita, Hironori Nakagami	3
5	CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy 2023 ·International Journal of Molecular Sciences ·(unknown), Linan Wang, Naohiro Seo, Satoshi Okumura, Tae Hayashi, Yasushi Akahori, Hiroshi Fujiwara, Yasunori Amaishi, Sachiko Okamoto, Junichi Mineno, Yoshimasa Tanaka, Takuma Kato, Hiroshi Shiku	11
6	Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia 2020 ·Biology of Blood and Marrow Transplantation ·Koji Kawamura, Yukië Tanaka, Hideki Nakasone, Yuko Ishihara, Shinichi Kako, Seiichiro Kobayashi, Yuetsu Tanaka, Tsukasa Ohmori, Kaoru Uchimaru, Sachiko Okamoto, Junichi Mineno, Hiroshi Shiku, Satoshi Nishimura, Yoshinobu Kanda	16
7	Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia 2016 ·Clinical Cancer Research ·Hiroki Tanaka, Hiroshi Fujiwara, Fumihiro Ochi, Kazushi Tanimoto, (unknown), Sachiko Okamoto, Junichi Mineno, Kiyotaka Kuzushima, Hiroshi Shiku, Takashi Sugiyama, A. John Barrett, Masaki Yasukawa	20
8	A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy 2016 ·PLoS ONE ·(unknown), Hiroshi Fujiwara, Kazushi Tanimoto, Sachiko Okamoto, Junichi Mineno, Kiyotaka Kuzushima, Hiroshi Shiku, Masaki Yasukawa	1
9	Direct tumor recognition by a human CD4+ T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses 2015 ·Scientific Reports ·Junko Matsuzaki, Takemasa Tsuji, Immanuel F. Luescher, Hiroshi Shiku, Junichi Mineno, Sachiko Okamoto, Lloyd J. Old, Protul Shrikant, Sacha Gnjatic, Kunle Odunsi	65
10	Gene-Modified Human α/β-T Cells Expressing a Chimeric CD16-CD3ζ Receptor as Adoptively Transferable Effector Cells for Anticancer Monoclonal Antibody Therapy 2014 ·Cancer Immunology Research ·Fumihiro Ochi, Hiroshi Fujiwara, Kazushi Tanimoto, Hiroaki Asai, (unknown), Sachiko Okamoto, Junichi Mineno, Kiyotaka Kuzushima, Hiroshi Shiku, J. Carl Barrett, Eiichi Ishii, Masaki Yasukawa	34
11	Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury 2014 ·Journal of Hematology & Oncology ·Hiroaki Asai, Hiroshi Fujiwara, Sohei Kitazawa, Naoto Kobayashi, Toshiki Ochi, (unknown), Fumihiro Ochi, Yoshiki Akatsuka, Sachiko Okamoto, Junichi Mineno, Kiyotaka Kuzushima, Hiroaki Ikeda, Hiroshi Shiku, Masaki Yasukawa	3
12	A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression 2012 ·Molecular Therapy — Nucleic Acids ·Sachiko Okamoto, Yasunori Amaishi, Yumi Goto, Hiroaki Ikeda, Hiroshi Fujiwara, Kiyotaka Kuzushima, Masaki Yasukawa, Hiroshi Shiku, Junichi Mineno	30
13	HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system 2012 ·Cancer Gene Therapy ·Teru Kanda, Toshiki Ochi, Hiroshi Fujiwara, Masaki Yasukawa, Sachiko Okamoto, Junichi Mineno, Kiyotaka Kuzushima, Tatsuya Tsurumi	1
14	Feasibility of gene-immunotherapy using WT1-specific T-cell receptor gene transfer for infant acute lymphoblastic leukemia with MLL gene rearrangement 2011 ·Blood Cancer Journal ·Kozo Nagai, Hiroshi Fujiwara, Toshiki Ochi, Sachiko Okamoto, Junichi Mineno, Hiroshi Shiku, Katsuyoshi Koh, K Sugita, Eiichi Ishii, Masaki Yasukawa	1
15	Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR 2009 ·Cancer Research ·Sachiko Okamoto, Junichi Mineno, Hiroaki Ikeda, Hiroshi Fujiwara, Masaki Yasukawa, Hiroshi Shiku, Ikunoshin Kato	143
16	Rapid αβ TCR-mediated responses in γδ T cells transduced with cancer-specific TCR genes 2009 ·Gene Therapy ·Atsunori Hiasa, Hiroyoshi Nishikawa, Masahiro Hirayama, Shigehisa Kitano, Sachiko Okamoto, Hideto Chono, S S Yu, Junichi Mineno, Yoshimasa Tanaka, Nagahiro Minato, Itaru Kato, Hiroshi Shiku	42
17	Hepatitis delta antigen binds to the clamp of RNA polymerase II and affects transcriptional fidelity 2007 ·Genes to Cells ·Yuki Yamaguchi, (unknown), Sittinan Chanarat, Sachiko Okamoto, Hiroshi Handa	37
18	P-TEFb-Mediated Phosphorylation of hSpt5 C-Terminal Repeats Is Critical for Processive Transcription Elongation 2006 ·Molecular Cell ·Tomoko Yamada, Yuki Yamaguchi, Naoto Inukai, Sachiko Okamoto, (unknown), Hiroshi Handa	295
19	Stimulation Side-Dependent Asymmetrical Secretion of Poly I:Poly C-Induced Interferon-β from Polarized Epithelial Cell Lines 1999 ·Biochemical and Biophysical Research Communications ·Sachiko Okamoto, (unknown), Yoshihiko Watanabe, Fumiyoshi Yamashita, Yoshinobu Takakura, Mitsuru Hashida	12
20	A physiological role of interferon (IFN)-β derived from tumor: tumor growth of a mouse bladder carcinoma line MBT-2 is partially suppressed by autocrine IFN-β 1997 ·Cancer Letters ·Kenji Kawabata, Sachiko Okamoto, Yoshinobu Takakura, Mitsuru Hashida, (unknown), Yoshihiko Watanabe	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact